Mima A
Adv Ther. 2022; 39(8):3488-3500.
PMID: 35751762
DOI: 10.1007/s12325-022-02223-0.
Sawaf H, Thomas G, Taliercio J, Nakhoul G, Vachharajani T, Mehdi A
J Clin Med. 2022; 11(2).
PMID: 35054076
PMC: 8781778.
DOI: 10.3390/jcm11020378.
Tan L, Du L, Carr M, Kuzin J, Moffett B, Chang A
World J Pediatr. 2010; 7(1):89-91.
PMID: 21191783
DOI: 10.1007/s12519-011-0252-1.
McMURRAY J, Matthews D
Br Heart J. 1986; 56(5):490.
PMID: 18610332
PMC: 1236903.
DOI: 10.1136/hrt.56.5.490-a.
Woodmansey P, Yeo W, Jackson P, Ramsay L
Postgrad Med J. 1994; 70(830):927-9.
PMID: 7870644
PMC: 2398015.
DOI: 10.1136/pgmj.70.830.927.
Drug therapy of renovascular hypertension.
Rosenthal T
Drugs. 1993; 45(6):895-909.
PMID: 7691497
DOI: 10.2165/00003495-199345060-00003.
Reversible acute on chronic renal failure during captopril treatment.
Verbeelen D, De Boel S
Br Med J (Clin Res Ed). 1984; 289(6436):20-1.
PMID: 6428648
PMC: 1442052.
DOI: 10.1136/bmj.289.6436.20.
Long-term effect of captopril on kidney function in various forms of hypertension.
Vetter W, Wehling M, Foerster E, Kuhlmann U, Boerlin H, Greminger P
Klin Wochenschr. 1984; 62(15):731-7.
PMID: 6387263
DOI: 10.1007/BF01725707.
Captopril-induced acute renal artery thrombosis and persistent anuria in a patient with documented pre-existing renal artery stenosis and renal failure.
Williams P, Hendy M, Ackrill P
Postgrad Med J. 1984; 60(706):561-3.
PMID: 6382225
PMC: 2417955.
DOI: 10.1136/pgmj.60.706.561.
Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.
Mujais S, Fouad F, Textor S, TARAZI R, Bravo E, Hart N
Br Heart J. 1984; 52(1):63-71.
PMID: 6378228
PMC: 481586.
DOI: 10.1136/hrt.52.1.63.
[Reproducibility of acute captopril-induced renal insufficiency with enalapril].
Cremer W
Klin Wochenschr. 1984; 62(1):43-5.
PMID: 6321850
DOI: 10.1007/BF01725192.
Renal function impairment induced by change in posture in patients with cirrhosis and ascites.
Bernardi M, Santini C, Trevisani F, Baraldini M, Ligabue A, Gasbarrini G
Gut. 1985; 26(6):629-35.
PMID: 3891534
PMC: 1432759.
DOI: 10.1136/gut.26.6.629.
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
Hommel E, Parving H, Mathiesen E, Edsberg B, Damkjaer Nielsen M, Giese J
Br Med J (Clin Res Ed). 1986; 293(6545):467-70.
PMID: 3091164
PMC: 1341107.
DOI: 10.1136/bmj.293.6545.467.
Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.
DiBianco R
Med Toxicol. 1986; 1(2):122-41.
PMID: 3023783
DOI: 10.1007/BF03259832.
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.
Funck-Brentano C, Chatellier G, Alexandre J
Br Heart J. 1986; 55(6):596-8.
PMID: 3013264
PMC: 1236768.
DOI: 10.1136/hrt.55.6.596.
Controlled trial of enalapril in congestive cardiac failure.
McGrath B, Arnolda L, Matthews P, Jackson B, Jennings G, Kiat H
Br Heart J. 1985; 54(4):405-14.
PMID: 2996575
PMC: 481919.
DOI: 10.1136/hrt.54.4.405.
Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
Reams G, Bauer J
Drugs. 1985; 30 Suppl 1:59-69.
PMID: 2994988
DOI: 10.2165/00003495-198500301-00009.
A need for new converting enzyme inhibitors?.
Ball S, Robertson J
Br Med J (Clin Res Ed). 1985; 290(6463):180-1.
PMID: 2981597
PMC: 1417972.
DOI: 10.1136/bmj.290.6463.180.
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure.
Speirs C, Dollery C, INMAN W, Rawson N, Wilton L
BMJ. 1988; 297(6652):830-2.
PMID: 2846102
PMC: 1834596.
DOI: 10.1136/bmj.297.6652.830.
Low-dose enalapril in severe chronic heart failure.
Brilla C, Kramer B, Hoffmeister H, Muller-Schauenburg W, Risler T, Seipel L
Cardiovasc Drugs Ther. 1989; 3(2):211-8.
PMID: 2562137
DOI: 10.1007/BF01883867.
